Vendor-Agnostic Automation for Cell and Gene Therapy Manufacturing genengnews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from genengnews.com Daily Mail and Mail on Sunday newspapers.
ScaleReady Launches With the Mission to Revolutionize T Cell Therapy Manufacturing
ScaleReady is a joint venture between Bio-Techne, Fresenius Kabi, and Wilson Wolf
ScaleReady s mission is to make the business of cell and gene therapy practical and viable by providing the most simple, scalable and versatile manufacturing platform in the industry
ScaleReady will provide sales, marketing, and application support for customers globally
ScaleReady, a joint venture between Bio-Techne (NASDAQ: TECH), Fresenius Kabi, and Wilson Wolf, launches today. The new company brings together proven tools and technologies for cell culture, cell activation, gene editing, and cell processing from its founding partners.